Direct measurement of pancreatic enzymes: a comparison of secretagogues.

Autor:	Pfefferkorn, Marian D, Fitzgerald, Joseph F, Croffie, Joseph M, Gupta, Sandeep K, Caffrey, Helena M
Předmět:	AMYLASES CHOLECYSTOKININ CLINICAL trials COMPARATIVE studies DIAGNOSIS DIFFERENTIAL diagnosis DIGESTIVE organs DRUG synergism FAILURE to thrive syndrome LIPASES LONGITUDINAL method MALABSORPTION syndromes RESEARCH methodology MEDICAL cooperation PROTEOLYTIC enzymes RESEARCH SECRETIN SECRETION TRYPSIN PILOT projects EVALUATION research
Zdroj:	Digestive Diseases & Sciences; Oct2002, Vol. 47 Issue 10, p2211-2216, 6p
Abstrakt:	Direct measurement of pancreatic enzymes is the gold standard in the evaluation of exocrine pancreatic function. The purpose of our study was to evaluate the use of cholecystokinin as a single-agent secretagogue for pancreatic drainage studies. Twenty pediatric patients received cholecystokinin (group 1) and 40 patients received either secretin plus placebo (group 2) or secretin plus cholecystokinin (group 3). Duodenal fluid was collected for measurement of lipase, amylase, trypsin, chymotrypsin. The mean lipase and amylase activities were higher in group 3 and the mean trypsin and chymotrypsin activities were higher in group 1, but none of these observations were statistically significant. Group 3 had more patients with all four enzymes being normal (75%) compared to groups 1 (60%) and 2 (50%) (P = 0.262). Patients in all three groups had at least one normal enzyme. Cholecystokinin is useful as a single agent for direct pancreatic enzyme measurements in the absence of commercially available secretin. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink